secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001295947-25-000037
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Consumer Q2 adj EPS $1.07 beats prior year; raises FY adj EPS guidance to $4.54-$4.58
--------------------------------------------------------------------------------

- Q2 revenue $274.1M (-3.4% YoY); diluted EPS $0.86 vs $1.09; adjusted EPS $1.07.
- Raises FY2026 adjusted diluted EPS outlook to $4.54-$4.58 (high end of prior range).
- Repurchased ~1.1M shares in Q2 for $75M; cumulative 1.6M shares in H1 for $109.8M.
- Clear Eyes supply constraints drove OTC revenue decline; expects improvement in H2 via capacity rebuild.
- Free cash flow guidance reaffirmed at $245M+; covenant leverage 2.4x.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594725000037/0001295947-25-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594725000037/pbh-20251106.htm
  HTML page:      https://secwatch.observer/filing/0001295947-25-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer